Abstract
The growing need for the characterization of cytochrome P450 (P450) metabolites often necessitates their synthesis up to Gram-scale. This task may in principle be achieved by using various techniques including chemical synthesis, the use of laboratory animals, in vitro P450 systems or microbial biotransformation. However, these approaches are in many instances unfavorable due to low yields, laborious purification, costs of cofactors, or the formation of non-physiologic metabolites. The fission yeast Schizosaccharomyces pombe has previously been shown by others and us to be very well suited for the heterologous expression of human P450s. In this study, we demonstrate whole-cell biotransformation reactions carried out with fission yeast strains that coexpress human cytochrome P450 reductase (CPR) and one of the following P450 isoforms: CYP2B6, CYP2C9, CYP2C19, CYP2D6, or CYP3A4, respectively. These strains could successfully convert their respective standard substrates but showed different responses with respect to incubation pH, the presence of glucose, and temperature, respectively. In addition, the preparative of synthesis of 2.8 g of 4′-hydroxydiclofenac was achieved by whole-cell biotransformation of diclofenac using a CPR-CYP2C9 coexpressing fission yeast strain.
Similar content being viewed by others
Abbreviations
- P450:
-
Cytochrome P450
- CPR:
-
Cytochrome P450 reductase
- DAD:
-
Diode array detector
- EMM:
-
Edinburgh Minimal Medium
- d.wt.:
-
Dry weight
- LC-MS/MS:
-
Liquid chromatography-tandem mass spectrometer
- MRM:
-
Multiple reaction monitoring
- MTP:
-
Microtiter plate
- NaPi:
-
Sodium phosphate buffer
- TMS:
-
Tetramethylsilane
References
FDA. (2008). Guidance for industry: Safety testing of drug metabolites in U.S. Department of Health and Human Services, F. a. D. A., Center for Drug Evaluation and Research (CDER) (Ed).
Strolin Benedetti, M., Whomsley, R., & Baltes, E. (2006). Expert Opinion on Drug Metabolism & Toxicology, 2, 895–921.
Bernhardt, R. (2005). Cytochrome P-450. In W. Lennarz, M. Lane, P. Modrich, J. Dixon, E. Carafoli, J. Exton, & D. Cleveland (Eds.), Encyclopedia of Biological Chemistry (pp. 544–549). New York: Academic.
Ingelman-Sundberg, M. (2004). Trends in Pharmacological Sciences, 25, 193–200.
Guengerich, F. P. (2006). The AAPS Journal, 8, E101–E111.
Jia, L., & Liu, X. (2007). Current Drug Metabolism, 8, 822–829.
Donato, M. T., Lahoz, A., Castell, J. V., & Gomez-Lechon, M. J. (2008). Current Drug Metabolism, 9, 1–11.
Urlacher, V. B., Lutz-Wahl, S., & Schmid, R. D. (2004). Applied Microbiology and Biotechnology, 64, 317–325.
Peters, F. T., Dragan, C. A., Wilde, D. R., Meyer, M. R., Zapp, J., Bureik, M., et al. (2007). Biochemical Pharmacology, 74, 511–520.
Peters, F. T., Dragan, C. A., Kauffels, A., Schwaninger, A. E., Zapp, J., Bureik, M., et al. (2009). Journal of Analytical Toxicology, 33, 190–197.
Peters, F. T., Dragan, C. A., Schwaninger, A. E., Sauer, C., Zapp, J., Bureik, M., et al. (2009). Forensic Science International, 184, 69–73.
Walsky, R. L., & Obach, R. S. (2004). Drug Metabolism and Disposition, 32, 647–660.
Yamazaki, S., Sato, K., Suhara, K., Sakaguchi, M., Mihara, K., & Omura, T. (1993). Journal of Biochemistry, 114, 652–657.
Yasumori, T. (1997). Expression of a human cytochrome P450 form in Schizosaccharomyces pombe: Comparison with expression in Saccharomyces cerevisiae. In Y. Giga-Hama & H. Kumagai (Eds.), Foreign gene expression in fission yeast Schizosaccharomyces pombe (pp 111–121). New York: Springer.
Yasumori, T., Chen, L. S., Li, Q. H., Ueda, M., Tsuzuki, T., Goldstein, J. A., et al. (1999). Biochemical Pharmacology, 57, 1297–1303.
Takanashi, K., Tainaka, H., Kobayashi, K., Yasumori, T., Hosakawa, M., & Chiba, K. (2000). Pharmacogenetics, 10, 95–104.
Rushmore, T. H., Reider, P. J., Slaughter, D., Assang, C., & Shou, M. (2000). Metabolic Engineering, 2, 115–125.
Hanlon, S. P., Friedberg, T., Wolf, C. R., Ghisalba, O., & Kittelmann, M. (2007). Recombinant yeast and bacteria that express human P450s: Bioreactors for drug discovery, development, and biotechnology. In R. D. Schmid & V. B. Urlacher (Eds.), Modern biooxidation: Enzymes, reactions and applications (pp 233–252). Chichester: Wiley.
Vail, R. B., Homann, M. J., Hanna, I., & Zaks, A. (2005). Journal of Industrial Microbiology & Biotechnology, 32, 67–74.
Webster, R., Pacey, M., Winchester, T., Johnson, P., & Jezequel, S. (1998). Applied Microbiology and Biotechnology, 49, 371–376.
Osorio-Lozada, A., Surapaneni, S., Skiles, G. L., & Subramanian, R. (2008). Drug Metabolism and Disposition, 36, 234–240.
Sambrook, J., & Russell, D. W. (2001). Molecular cloning: A laboratory manual (3rd ed.). Cold Spring Harbor: Cold Spring Harbor Press.
Moreno, S., Klar, A., & Nurse, P. (1991). Methods Enzymol, 194, 795–823.
Alfa, C., Fantes, P., Hyams, J., McLeod, M., & Warbrick, E. (1993). Experiments with fission yeast. A laboratory course manual. Cold Spring Harbor Press, Cold Spring Harbor, NY.
Dragan, C. A., Zearo, S., Hannemann, F., Bernhardt, R., & Bureik, M. (2005). FEMS Yeast Research, 5, 621–625.
Maundrell, K. (1993). Gene, 123, 127–130.
Suga, M., & Hatakeyama, T. (2005). Yeast, 22, 799–804.
Okazaki, K., Okazaki, N., Kume, K., Jinno, S., Tanaka, K., & Okayama, H. (1990). Nucleic Acids Research, 18, 6485–6489.
Cheng, J., Wan, D. F., Gu, J. R., Gong, Y., Yang, S. L., Hao, D. C., et al. (2006). Protein Expression and Purification, 47, 467–476.
Masimirembwa, C. M., Otter, C., Berg, M., Jonsson, M., Leidvik, B., Jonsson, E., et al. (1999). Drug Metabolism and Disposition, 27, 1117–1122.
Dragan, C. A., Hartmann, R. W., & Bureik, M. (2006). Journal of Enzyme Inhibition and Medicinal Chemistry, 21, 547–556.
Dragan, C. A., Blank, L. M., & Bureik, M. (2006). Yeast, 23, 779–794.
Truan, G., Cullin, C., Reisdorf, P., Urban, P., & Pompon, D. (1993). Gene, 125, 49–55.
Peyronneau, M. A., Renaud, J. P., Truan, G., Urban, P., Pompon, D., & Mansuy, D. (1992). European Journal of Biochemistry, 207, 109–116.
Shen, S., Marchick, M. R., Davis, M. R., Doss, G. A., & Pohl, L. R. (1999). Chemical Research in Toxicology, 12, 214–222.
Bureik, M., Schiffler, B., Hiraoka, Y., Vogel, F., & Bernhardt, R. (2002). Biochemistry, 41, 2311–2321.
Paine, M. J., Gilham, D., Roberts, G. C., & Wolf, C. R. (1996). Archives of Biochemistry and Biophysics, 328, 143–150.
Huang, H., Yang, X., Li, Q., Sun, L., & Zhong, D. (2006). Applied Microbiology and Biotechnology, 72, 486–491.
Losson, R., & Lacroute, F. (1983). Cell, 32, 371–377.
Acknowledgements
This work was supported by a grant (ChemBioTec 13220-32) from the Deutsche Bundesstiftung Umwelt (DBU).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Drăgan, CA., Peters, F.T., Bour, P. et al. Convenient Gram-Scale Metabolite Synthesis by Engineered Fission Yeast Strains Expressing Functional Human P450 Systems. Appl Biochem Biotechnol 163, 965–980 (2011). https://doi.org/10.1007/s12010-010-9100-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12010-010-9100-3